Nov 02, 2018
Did you know that Calciphylaxis, or calcific uremic arteriolopathy (CUA), although affects merely 1 to 4 % of patients undergoing dialysis, has a dismal prognosis with up to 80% mortality? In addition to numerous comorbidities which affect the majority of dialysis patients, Calciphylaxis is a painful and often fatal...
Read More...
DAWNZERA’s EU Approval Strengthens the Hereditary Angioedema Treatment Landscape
Jan 30, 2026
Understanding Bone Densitometers: Technology, Applications, and Impact on Bone Health
Nov 04, 2025
Wireless Brain Sensors: Revolutionizing Neuroscience and Healthcare
Oct 28, 2025
The Dynamic Landscape of Myelofibrosis Treatment: A 2024 Perspective
Jun 10, 2024
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper